Qingdao Baheal Medical INC. (SHE:301015)
China
· Delayed Price · Currency is CNY 17.77
-0.40 (-2.20%)
Apr 28, 2025, 2:45 PM CST
SHE:301015 Ratios and Metrics
Market cap in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | Current | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
|---|---|---|---|---|---|---|---|
Period Ending | Apr '25 Apr 25, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Jan '22 Jan 1, 2022 | Dec '20 Dec 31, 2020 | 2015 - 2019 |
| Market Capitalization | 9,551 | 12,725 | 18,830 | 12,518 | 15,911 | - | Upgrade
|
| Market Cap Growth | -37.01% | -32.42% | 50.42% | -21.32% | - | - | Upgrade
|
| Enterprise Value | 10,506 | 13,693 | 19,206 | 12,782 | 15,944 | - | Upgrade
|
| Last Close Price | 18.17 | 24.21 | 34.98 | 22.64 | 27.88 | - | Upgrade
|
| PE Ratio | 16.50 | 18.40 | 26.44 | 24.93 | 37.74 | - | Upgrade
|
| Forward PE | 12.71 | 13.27 | 25.05 | 21.53 | 33.48 | - | Upgrade
|
| PS Ratio | 1.18 | 1.57 | 2.28 | 1.67 | 2.26 | - | Upgrade
|
| PB Ratio | 3.52 | 4.89 | 6.04 | 5.49 | 7.32 | - | Upgrade
|
| P/TBV Ratio | 4.49 | 6.25 | 7.12 | 5.58 | 7.50 | - | Upgrade
|
| P/FCF Ratio | 16.26 | 24.96 | 30.67 | 62.46 | 103.45 | - | Upgrade
|
| P/OCF Ratio | 11.02 | 15.64 | 23.55 | 40.94 | 87.76 | - | Upgrade
|
| EV/Sales Ratio | 1.30 | 1.69 | 2.33 | 1.70 | 2.26 | - | Upgrade
|
| EV/EBITDA Ratio | 10.32 | 13.25 | 17.30 | 17.37 | 25.05 | - | Upgrade
|
| EV/EBIT Ratio | 11.12 | 13.95 | 18.25 | 17.94 | 25.94 | - | Upgrade
|
| EV/FCF Ratio | 17.89 | 26.86 | 31.28 | 63.77 | 103.66 | - | Upgrade
|
| Debt / Equity Ratio | 0.95 | 0.92 | 0.47 | 0.59 | 0.56 | 0.90 | Upgrade
|
| Debt / EBITDA Ratio | 2.52 | 2.26 | 1.28 | 1.74 | 1.87 | 3.12 | Upgrade
|
| Debt / FCF Ratio | 4.37 | 4.68 | 2.37 | 6.67 | 7.97 | - | Upgrade
|
| Asset Turnover | 1.25 | 1.20 | 1.44 | 1.56 | 1.64 | 1.58 | Upgrade
|
| Inventory Turnover | 6.95 | 5.84 | 7.28 | 8.52 | 8.55 | 8.05 | Upgrade
|
| Quick Ratio | 1.22 | 1.19 | 1.69 | 1.29 | 1.38 | 1.13 | Upgrade
|
| Current Ratio | 1.56 | 1.57 | 2.14 | 1.64 | 1.70 | 1.42 | Upgrade
|
| Return on Equity (ROE) | 24.45% | 26.80% | 28.55% | 21.80% | 22.60% | 19.77% | Upgrade
|
| Return on Assets (ROA) | 9.12% | 9.07% | 11.49% | 9.25% | 8.93% | 6.96% | Upgrade
|
| Return on Capital (ROIC) | 12.19% | 12.83% | 16.06% | 12.69% | 12.30% | 9.73% | Upgrade
|
| Return on Capital Employed (ROCE) | 23.90% | 25.50% | 26.10% | 29.40% | 27.90% | 27.50% | Upgrade
|
| Earnings Yield | 6.18% | 5.44% | 3.78% | 4.01% | 2.65% | - | Upgrade
|
| FCF Yield | 6.15% | 4.01% | 3.26% | 1.60% | 0.97% | - | Upgrade
|
| Dividend Yield | 4.19% | 3.15% | - | 3.37% | 2.39% | - | Upgrade
|
| Payout Ratio | 77.60% | 65.05% | 61.81% | 80.11% | 13.22% | 54.61% | Upgrade
|
| Buyback Yield / Dilution | 0.90% | -0.92% | -2.37% | -5.44% | -5.50% | 0.49% | Upgrade
|
| Total Shareholder Return | 5.09% | 2.23% | -2.37% | -2.07% | -3.11% | 0.49% | Upgrade
|
Source: S&P Global Market Intelligence. Standard template. Financial Sources.